Feed / ACHV

Achieve Life Sciences, Inc.

ACHV

Healthcare · 8.31 +36.1% today

Dominant mover · weak group confirmationMarket checked 20 Aug, 09:30 GMT-4

Jodie situation report

ACHV dominates a concentrated Cancer and Nicotine Therapies move.

ACHV accounts for 83.5% of the group's measured movement across 1.4 effective names. raw member direction is mixed; 2 of 3 session-normalized paths align to the upside. Capital-flow agreement is 21%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveDominant mover#1 of 3 by movement share
Group movement share83.5%Absolute path energy—not portfolio weight
Relative path+11.00%aligned
Effective breadth1.4 / 3concentrated
Relative alignment2/3upside path · 1 counter-moving
Capital-flow agreement21%not yet clean
SEQUENCE READ

DCTH, NVCR moved materially before ACHV. ACHV crossed its material path threshold at 12:10 ET, 130 minutes after the first measured mover.

EVIDENCE COVERAGE

3 of 3 members in Cancer and Nicotine Therapies are active. 0 of 2 disclosed connections are confirming.

What would change this read
  • At least 2 of 3 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as CADL begins moving with the group.

Invalidation: The live read weakens if participation falls to 1 of 3 members or fewer.

Watch this read

Who this business touches

The relationships behind ACHV

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

OMCOmnicom Group Inc.partnerMay 12, 2026

Furthermore, we have entered into a partnership with Omnicom to support the commercial launch of cytisinicline in the United States, which requires financial commitments in advance of approval and may result is less oversight by us or disruption in our commer…

RSReliance, Inc.partnerNov 6, 2025

Risks Related to Our Reliance on Third Parties We expect to continue to rely on third parties to manufacture cytisinicline.

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ACHV is currently a Early Follower in the organic co-movement group Cancer and Nicotine Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.